EDITOR-IN-CHIEF

Xianwei Ye M.D., Ph.D.

Professor, Director

State Key Laboratory of Pulmonary Immune Diseases, National Health Commission of the People's Republic of China
Department of Respiration and Critical Care Medicine, Guizhou Provincial People's Hospital, Guizhou University, China

Representative Publications:

1.Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407-418. doi: 10.1016/S0140-6736(19)31147-X. PMID: 31230828

2.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. PMID: 29650248

3.IL-33 Treatment Attenuates the Systemic Inflammation Reaction in Acinetobacter baumannii Pneumonia by Suppressing TLR4/NF-κB Signaling. Inflammation. 2018;41(3):870-877. doi: 10.1007/s10753-018-0741-7. PMID: 29508184

4.Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. N Engl J Med. 2017;377(10):923-935. doi: 10.1056/NEJMoa1700228. PMID: 28877027